A 42-year-old woman from rural Maharashtra presents with a 3-month history of polyuria, polydipsia, and a 4 kg weight loss. She reports no significant family history of diabetes. On examination, she is lean (BMI 19 kg/m²) and appears malnourished. Fasting blood glucose is 280 mg/dL, and HbA1c is 11.2%. C-peptide level is 0.8 ng/mL (normal 0.8–3.1). Serum ketones are positive. Islet cell antibodies (ICA) and glutamic acid decarboxylase (GAD) antibodies are both positive. What is the most likely pathological mechanism underlying her diabetes?

Explanation

## Pathological Diagnosis: Type 1 Diabetes Mellitus ### Clinical Features Supporting Type 1 DM **Key Point:** This patient presents with classic features of Type 1 DM: acute onset in a lean individual, positive autoimmune markers (ICA and GAD antibodies), low C-peptide (indicating severe beta cell dysfunction), and presence of ketosis. ### Pathological Mechanism **High-Yield:** Type 1 DM is characterized by **autoimmune-mediated destruction of pancreatic beta cells** in the islets of Langerhans. The pathological sequence includes: 1. **Genetic predisposition** — HLA-DR3/DR4 haplotypes increase susceptibility 2. **Environmental trigger** — viral infection (enterovirus, rotavirus) or molecular mimicry 3. **Autoimmune activation** — CD8+ T cells infiltrate islets (insulitis) 4. **Beta cell apoptosis** — progressive loss of insulin-secreting capacity 5. **Clinical presentation** — when ~80–90% of beta cells are destroyed ### Diagnostic Markers | Marker | Significance | | --- | --- | | **ICA (Islet Cell Antibodies)** | Present in 80% of Type 1 DM at diagnosis | | **GAD65 Antibodies** | Most specific; present in 70–80% | | **IA-2 Antibodies** | Present in 50–60% | | **Zinc Transporter 8 (ZnT8)** | Emerging marker; 50% positive | | **C-peptide** | Low/absent (reflects endogenous insulin secretion) | **Clinical Pearl:** The presence of **two or more autoimmune markers** (ICA + GAD in this case) confirms autoimmune etiology and distinguishes Type 1 DM from Type 2 DM or MODY. ### Pathological Histology **Key Point:** Pancreatic biopsy (rarely done clinically) would show: - **Insulitis** — infiltration of islets by CD8+ T lymphocytes and macrophages - **Selective beta cell loss** — alpha and delta cells preserved - **Fibrosis** — in chronic stages ### Why C-Peptide is Low C-peptide is cleaved from proinsulin during insulin synthesis. Low C-peptide (0.8 ng/mL, at the lower limit) reflects **severely reduced beta cell mass and function**. In Type 2 DM, C-peptide would be normal or elevated (compensatory hyperinsulinemia). ### Ketosis in Type 1 DM **High-Yield:** Positive serum ketones indicate **absolute insulin deficiency**. Without insulin, lipolysis accelerates, producing free fatty acids that are oxidized to ketone bodies (acetoacetate, beta-hydroxybutyrate, acetone). This distinguishes Type 1 from Type 2 DM, where residual insulin prevents ketosis in most cases. **Mnemonic: AUTOIMMUNE MARKERS in Type 1 DM — ICA, GAD, IA-2, ZnT8** (remember: ICA is earliest, GAD most specific).